Cargando…
P1360: CLINICAL TRANSLATION OF A NOVEL, POTENT AND WELL-CHARACTERIZED INDUCED REGULATORY T-CELL PRODUCT AGAINST GRAFT VERSUS HOST DISEASE
Autores principales: | Lysandrou, Memnon, Kefala, Dionysia, Christofi, Panayiota, Georgia Papagianni, Penelope, Mingos, Antonis, Pieridou, Chryso, Vlachonikola, Elisavet, Kyriakou, Maria, Lydia Chatzidaniil, Alexandra, Savvopoulos, Nikolaos, Papadopoulou, Anastasia, Chatzidimitriou, Anastasia, Costeas, Paul, Yannaki, Evangelia, Spyridonidis, Alexandros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430657/ http://dx.doi.org/10.1097/01.HS9.0000972328.41871.bb |
Ejemplares similares
-
Hypomethylation-induced regulatory programs in T cells unveiled by transcriptomic analyses
por: Lysandrou, Memnon, et al.
Publicado: (2023) -
Study protocol: Phase I/II trial of induced HLA-G(+) regulatory T cells in patients undergoing allogeneic hematopoietic cell transplantation from an HLA-matched sibling donor
por: Lysandrou, Memnon, et al.
Publicado: (2023) -
Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming
por: Alvanou, Maria, et al.
Publicado: (2023) -
T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword
por: Vlachonikola, Elisavet, et al.
Publicado: (2021) -
T Cell Defects and Immunotherapy in Chronic Lymphocytic Leukemia
por: Vlachonikola, Elisavet, et al.
Publicado: (2021)